| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013631083 |
| P356 | DOI | 10.1046/J.0022-202X.2001.01454.X |
| P698 | PubMed publication ID | 11564180 |
| P50 | author | Nicholas JC King | Q55186402 |
| Scott N Byrne | Q60327799 | ||
| P2093 | author name string | Johnston LJ | |
| Halliday GM | |||
| P2860 | cites work | A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. | Q53438021 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | West Nile virus | Q158856 |
| P304 | page(s) | 702-709 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice | |
| P478 | volume | 117 |
| Q27481089 | Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion |
| Q33641517 | Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection |
| Q84764268 | Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration |
| Q35085660 | Antiviral macrophage responses in flavivirus encephalitis |
| Q27472780 | CD8+ T Cells Require Perforin To Clear West Nile Virus from Infected Neurons |
| Q27480936 | Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms |
| Q92154829 | Cellular microRNA-155 Regulates Virus-Induced Inflammatory Response and Protects against Lethal West Nile Virus Infection |
| Q28395291 | Central roles of NLRs and inflammasomes in viral infection |
| Q29198018 | Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis |
| Q92631295 | Comparative Pathology of West Nile Virus in Humans and Non-Human Animals |
| Q35152251 | Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis |
| Q34983449 | Dendritic cells: making progress with tumour regression? |
| Q37376398 | Differential virulence and pathogenesis of West Nile viruses |
| Q27487142 | Early B-Cell Activation after West Nile Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor Signaling |
| Q33911897 | Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q36096374 | Experimental West Nile Virus Infection in Rabbits: An Alternative Model for Studying Induction of Disease and Virus Control |
| Q27484988 | Fas Ligand Interactions Contribute to CD8+ T-Cell-Mediated Control of West Nile Virus Infection in the Central Nervous System |
| Q37765386 | Flavivirus encephalitis: pathological aspects of mouse and other animal models |
| Q27473224 | Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection |
| Q50536561 | Host Competence: An Organismal Trait to Integrate Immunology and Epidemiology. |
| Q37673163 | IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts |
| Q27340022 | IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection |
| Q35613326 | Immune modulation by flaviviruses |
| Q38068093 | Immune responses to West Nile virus infection in the central nervous system |
| Q33584872 | Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery |
| Q34406807 | Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus |
| Q91971766 | Indispensable Role of CX3CR1+ Dendritic Cells in Regulation of Virus-Induced Neuroinflammation Through Rapid Development of Antiviral Immunity in Peripheral Lymphoid Tissues |
| Q28593473 | Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis |
| Q34542855 | Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus |
| Q35382179 | Innate immune control of West Nile virus infection |
| Q35129744 | Interaction of flaviviruses with cells of the vertebrate host and decoy of the immune response |
| Q38836537 | Lessons from the Murine Models of West Nile Virus Infection |
| Q36780133 | Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development |
| Q33821633 | Modulation of innate immune signaling by the secreted form of the West Nile virus NS1 glycoprotein |
| Q33238490 | Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion |
| Q42987948 | Mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses |
| Q27009096 | Neurological approaches for investigating West Nile virus disease and its treatment in rodents |
| Q39563308 | Neutralization escape variant of West Nile virus associated with altered peripheral pathogenicity and differential cytokine profile |
| Q27473291 | PKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in Neurons |
| Q52345134 | Parasite Tolerance and Host Competence in Avian Host Defense to West Nile Virus. |
| Q27477543 | Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion |
| Q35613343 | Pathogenesis of flavivirus encephalitis |
| Q21144412 | Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection |
| Q42996855 | Replication of West Nile virus in equine peripheral blood mononuclear cells |
| Q30837482 | Role of skin immune cells on the host susceptibility to mosquito-borne viruses |
| Q37955411 | Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe? |
| Q87413648 | Skin sensitization induced Langerhans' cell mobilization: variable requirements for tumour necrosis factor-α |
| Q34937936 | TNF-α acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following Japanese encephalitis virus infection |
| Q35826994 | Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7. |
| Q38157732 | The innate immune playbook for restricting West Nile virus infection |
| Q40480648 | The kinetics of proinflammatory cytokines in murine peritoneal macrophages infected with envelope protein-glycosylated or non-glycosylated West Nile virus. |
| Q38006657 | The role of chemokines in the pathogenesis of neurotropic flaviviruses |
| Q27487955 | The structural immunology of antibody protection against West Nile virus |
| Q27490290 | Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection |
| Q56893328 | Viral diseases of the central nervous system |
| Q27488431 | West Nile Virus Capsid Degradation of Claudin Proteins Disrupts Epithelial Barrier Function |
| Q26766121 | West Nile Virus Infection in the Central Nervous System |
| Q56932479 | West Nile virus |
| Q38074266 | West Nile virus infection and immunity |
| Q35159163 | West Nile virus infection induces depletion of IFNAR1 protein levels |
| Q30227143 | West nile virus: characteristics of an african virus adapting to the third millennium world. |
Search more.